Page last updated: 2024-09-05
biotin and rolipram
biotin has been researched along with rolipram in 1 studies
Compound Research Comparison
Studies
(biotin) | Trials
(biotin) | Recent Studies (post-2010)
(biotin) | Studies
(rolipram) | Trials
(rolipram) | Recent Studies (post-2010) (rolipram) |
|---|
| 14,847 | 95 | 3,882 | 1,604 | 17 | 401 |
Protein Interaction Comparison
| Protein | Taxonomy | biotin (IC50) | rolipram (IC50) |
|---|
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 1.2233 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | | 1.2233 |
| Retina-specific copper amine oxidase | Homo sapiens (human) | | 0.0003 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 1.0975 |
| 3',5'-cyclic-AMP phosphodiesterase | Sus scrofa (pig) | | 3.63 |
| Renin | Homo sapiens (human) | | 3.5 |
| Tumor necrosis factor | Homo sapiens (human) | | 0.35 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | | 0.7287 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | | 0.7287 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | | 0.8447 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | | 1.1942 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | | 0.095 |
| Delta-type opioid receptor | Mus musculus (house mouse) | | 1.5 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | | 1.5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | | 0.7287 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | | 0.835 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | | 1.1005 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | | 1.61 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | | 1.0794 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | | 0.835 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | | 2 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | Homo sapiens (human) | | 0.835 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | Homo sapiens (human) | | 0.835 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Homo sapiens (human) | | 0.835 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Bregman, BS; Dai, H; Finn, T; Hamers, FP; Hockenbury, N; MacArthur, L; Mansfield, K; McAtee, M; McHugh, B; Tidwell, JL | 1 |
Other Studies
1 other study(ies) available for biotin and rolipram
| Article | Year |
|---|
Activity-based therapies to promote forelimb use after a cervical spinal cord injury.Journal of neurotrauma, 2009, Volume: 26, Issue:10
Topics: Animals; Biotin; Cervical Vertebrae; Dextrans; Disease Models, Animal; Environment, Controlled; Exercise Therapy; Exploratory Behavior; Female; Forelimb; Gait Disorders, Neurologic; Movement Disorders; Neuronal Plasticity; Neuronal Tract-Tracers; Paralysis; Phosphodiesterase Inhibitors; Physical Conditioning, Animal; Pyramidal Tracts; Rats; Rats, Sprague-Dawley; Recovery of Function; Rolipram; Spinal Cord Injuries; Treatment Outcome | 2009 |